5/9
07:06 am
aplt
Applied Therapeutics Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Low
Report
Applied Therapeutics Reports First Quarter 2024 Financial Results [Yahoo! Finance]
5/9
07:00 am
aplt
Applied Therapeutics Reports First Quarter 2024 Financial Results
Low
Report
Applied Therapeutics Reports First Quarter 2024 Financial Results
5/7
07:00 am
aplt
Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference
Low
Report
Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference
4/15
07:10 am
aplt
Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer [Yahoo! Finance]
Low
Report
Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer [Yahoo! Finance]
4/15
07:00 am
aplt
Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
Low
Report
Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
4/11
11:00 am
aplt
Applied Therapeutics, Inc. (NASDAQ: APLT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $12.00 price target on the stock.
Low
Report
Applied Therapeutics, Inc. (NASDAQ: APLT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $12.00 price target on the stock.
4/4
07:19 am
aplt
Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024 [Yahoo! Finance]
Medium
Report
Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024 [Yahoo! Finance]
4/4
07:00 am
aplt
Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
Low
Report
Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
3/28
04:43 pm
aplt
Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia [Yahoo! Finance]
Medium
Report
Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia [Yahoo! Finance]
3/28
04:30 pm
aplt
Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
Medium
Report
Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
3/26
08:44 am
aplt
Applied Therapeutics, Inc. (NASDAQ: APLT) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $12.00 price target on the stock.
Medium
Report
Applied Therapeutics, Inc. (NASDAQ: APLT) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $12.00 price target on the stock.
3/13
11:38 am
aplt
Applied Therapeutics (APLT) Surges 124% in a Month: Here's Why [Yahoo! Finance]
Low
Report
Applied Therapeutics (APLT) Surges 124% in a Month: Here's Why [Yahoo! Finance]
3/8
04:50 am
aplt
Applied Therapeutics Inc (APLT) Announces Year-End 2023 Financial Results and Clinical Progress [Yahoo! Finance]
Low
Report
Applied Therapeutics Inc (APLT) Announces Year-End 2023 Financial Results and Clinical Progress [Yahoo! Finance]
3/6
01:35 pm
aplt
Applied Therapeutics, Inc. (NASDAQ: APLT) had its price target raised by analysts at UBS Group AG from $4.00 to $12.00. They now have a "buy" rating on the stock.
Medium
Report
Applied Therapeutics, Inc. (NASDAQ: APLT) had its price target raised by analysts at UBS Group AG from $4.00 to $12.00. They now have a "buy" rating on the stock.
3/6
07:12 am
aplt
Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results [Yahoo! Finance]
Low
Report
Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results [Yahoo! Finance]
3/6
07:00 am
aplt
Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
Medium
Report
Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
2/28
01:11 pm
aplt
FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder [Yahoo! Finance]
Neutral
Report
FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder [Yahoo! Finance]
2/28
08:20 am
aplt
Applied Therapeutics Announces $100 Million Private Placement [Yahoo! Finance]
High
Report
Applied Therapeutics Announces $100 Million Private Placement [Yahoo! Finance]
2/28
08:14 am
aplt
Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia [Yahoo! Finance]
Medium
Report
Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia [Yahoo! Finance]
2/28
08:05 am
aplt
Applied Therapeutics Announces $100 Million Private Placement
Low
Report
Applied Therapeutics Announces $100 Million Private Placement
2/28
08:00 am
aplt
Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia
High
Report
Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia
2/24
05:30 am
aplt
Applied Therapeutics, Inc. (NASDAQ: APLT) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.
Medium
Report
Applied Therapeutics, Inc. (NASDAQ: APLT) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.
2/22
07:11 am
aplt
Applied Therapeutics, Inc. (NASDAQ: APLT) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $12.00 price target on the stock.
Medium
Report
Applied Therapeutics, Inc. (NASDAQ: APLT) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $12.00 price target on the stock.
2/16
04:00 pm
aplt
Applied Therapeutics: Speedy Regulatory Review Of Govorestat Might Be Possible [Seeking Alpha]
Low
Report
Applied Therapeutics: Speedy Regulatory Review Of Govorestat Might Be Possible [Seeking Alpha]
2/16
01:05 pm
aplt
Applied Therapeutics hits 52-week high on trial success [Seeking Alpha]
High
Report
Applied Therapeutics hits 52-week high on trial success [Seeking Alpha]